HeartFlow is set to be listed on the Nasdaq under the symbol ‘HTFL’. Seeking a valuation of $1.46bn, the California-based company aims to raise $300m by offering 16.7 million shares priced between $17 ...

MedTech Europe has reiterated the importance of tariff-free trade for medical technologies following the US decision to impose reciprocal tariffs of 15% on most goods from Europe.

Microbot Medical has secured a non-dilutive NIS2.15m (around $630,000) grant from the Israel Innovation Authority (IIA).

The FDA has granted a second 510(k) clearance to expand the use of Respiree’s RS001 cardio-respiratory wearable to home use.